What is MS Phase 3 study Baclofen ER?

Category: Others

false

NCT01457352 is a randomized, placebo-controlled study to evaluate safety and efficacy of an extended release version of baclofen for treating muscle spasticity in patient with multiple sclerosis. Other study names are CLR_09_21.

No patients have reported taking MS Phase 3 study Baclofen ER.
Last updated:
There are no evaluations for MS Phase 3 study Baclofen ER.